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Abstract 
Neuropeptides are key messengers in almost all physiological processes. They originate from 
larger precursors and are extensively processed to become bioactive. Neuropeptidomics aims 
to comprehensively identify the collection of neuropeptides in an organism, organ, tissue or 
cell. The neuropeptidome of several invertebrates is thoroughly explored since they are 
important model organisms (and models for human diseases), disease vectors and pest 
species. The charting of the neuropeptidome is the first step towards understanding 
peptidergic signaling. This review will first discuss the latest developments in exploring the 
neuropeptidome. The physiological roles and modes of action of neuropeptides can be 
explored in two ways, which are largely orthogonal and therefore complementary. The first 
way consists of inferring the functions of neuropeptides by a forward approach where 
neuropeptide profiles are compared under different physiological conditions. Second is the 
reverse approach were neuropeptide collections are used to screen for receptor-binding. This 
is followed by localization studies and functional tests. This review will focus on how these 
different functional screening methods contributed to the field of invertebrate 
neuropeptidomics and expanded our knowledge of peptidergic signaling. 
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Abbreviations 
CE   Capillary electrophoresis 
CHO   Chinese hamster ovary 
CNS   Central nervous system 
DiLeu   N,N-dimethyl leucine 
dsRed   Red fluorescent protein 
GFP   Green fluorescent protein 
GPCRs  G-protein coupled receptors 
HEK   Human embryonic kidney 
IMS   Imaging mass spectrometry 
iTRAQ  Isobaric tags for relative and absolute quantification 
LC   Liquid chromatography 
MALDI-TOF  Matrix-assisted laser desorption/ionization time-of-flight 
MS   Mass spectrometry 
MS/MS  Tandem mass spectrometry 
PCR   Polymerase chain reaction 
RNAi   RNA interference 
RP-HPLC   Reversed-phase high-performance liquid chromatography 
RTKs   Receptor tyrosine kinases 
SILAC  Stable isotope labeling with amino acids in cell cultures 
TMAB  4-trimethylammoniumbutyryl 
TMT   Tandem mass tags 
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1. Introduction 
There are several classes of endogenous bioactive peptides, for example antimicrobial (or 
antifungal) peptides that are active in host-defense [1,2], but the most common class consists 
of (neuro-)endocrine signaling molecules. Peptidergic signaling is crucial for all multicellular 
life, as correct responses to changing environments or internal stressors require 
communication between different specialized cells and tissues. While peptidergic signals may 
originate from non-neuronal tissues (e.g. insulin), many endogenous peptides are neuronal in 
nature, and these so-called neuropeptides may act as neurohormones, neurotransmitters or 
neuromodulators [3]. 
Neuropeptides are directly encoded in the genome and are initially produced as large 
precursor molecules, called preprohormones. All have an amino-terminal signal peptide 
which is immediately removed upon arrival in the endoplasmic reticulum [4]. The remaining 
prohormone is commonly cleaved at mono- or dibasic sites by endopeptidases within the 
Golgi apparatus and immature secretory granules, to release the fully processed peptides [5,6]. 
In addition, many neuropeptides require further post-translational processing for their 
biological activity and stability, such as removal of the C-terminal basic residues, amidation, 
glycosylation, acetylation, sulfation or phosphorylation (Fig. 1). In their mature bioactive 
form, peptide length ranges from as short as 3 (e.g. thyrotropin-releasing hormone) to more 
than 100 amino acids [7]. Signaling peptides exert their function by binding to receptors, 
resulting in the activation of intracellular signaling pathways and a physiological response 
[8,9]. Therefore, signaling peptides, their receptors and downstream effectors are functional 
units of peptidergic signaling and require to be studied all in order to understand their 
physiological functions [10]. 
Peptidergic signaling has been extensively studied in a multitude of invertebrate species 
because of their economic importance as pest species (e.g. locusts such as Schistocerca 
gregaria or Locusta migratoria and the flour beetle Tribolium castaneum), disease vectors 
(e.g. the tsetse fly Glossina morsitans) or as beneficial pollinators (e.g. the honey bee Apis 
mellifera). Furthermore, several invertebrate models such as the nematode Caenorhabditis 
elegans or the fruit fly Drosophila melanogaster lend themselves well as model organisms for 
the study of endocrine signaling, due to their relative simplicity and the existence of extensive 
genetic toolsets. C. elegans and D. melanogaster are used as models for neurodegenerative 
diseases, which have important neuropeptidergic components [11,12]. In these invertebrates, 
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neuropeptidergic signaling has also been linked to various evolutionarily conserved 
developmental, physiological and behavioral processes such as learning and memory [13,14], 
defecation [15], locomotion [16–18], longevity [19,20], reproduction [21,22] and others (as 
further reviewed by Taghert and Nitabach [23] and by Caers et al. [9]).  
 
Fig. 1: Schematic overview of bioactive peptide processing in the secretory pathway. Peptides are 
first produced as preprohormones, which possess an amino-terminal signal peptide. This signal peptide 
is removed by a signal peptidase upon arrival in the rough endoplasmic reticulum (RER), which enters 
the peptide into the secretory pathway. The remaining prohormone is sent to the Golgi complex and is 
commonly cleaved at mono- or dibasic sites (often KR) by proprotein convertases after which the 
mono- or dibasic site is removed by carboxypeptidases. In addition, many endogenous peptides are 
further processed, e.g. C-terminal glycines provide the amine groups for C-terminal amino acids of 
amidated peptides (pictured here), and peptides can be glycosylated, pyroglutamated, acetylated, 
sulfated or phosphorylated. In their fully processed bioactive form, peptides are gathered in secretory 
granules and released after stimulation [4–7]. 
 
The large-scale study of the function, expression and structure of endogenous peptides has 
been termed peptidomics, and can be considered a specialized off-shoot of the domain of 
proteomics and functional genomics [24–26]. Neuropeptidomics is the subfield of 
peptidomics that is focused on neuropeptides. Several techniques native to the domain of 
proteomics have been adapted for use in peptidomics studies (as reviewed by Boonen et al. 
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[27]) and applying these techniques has led to significant advances in the study of bioactive 
peptides. 
This review will discuss the recent developments in charting the neuropeptidome of 
invertebrates, the first step to unravel peptidergic signaling pathways. We will further discuss 
how peptidomics techniques have contributed to knowledge of peptidergic signaling in 
invertebrates, from receptor binding to physiological functions. Two main screening 
approaches will be illustrated, a forward approach where peptide expression profiles are 
correlated with physiological conditions, and a reverse approach, where receptors (usually G-
protein coupled receptors or GPCRs) are screened with neuropeptide collections (from 
peptidomic studies) for peptide binding. 
 
2. Recent developments related to peptidomics technology 
Peptidomics aims to identify the endogenous peptide complement in cells, organs, tissues and 
organisms. The functional forms of neuropeptides can be hard to predict from the genome 
because of their extensive processing (similar difficulties occur with splicing and protein 
modification in proteomics) and physical detection methods are an essential support to 
genomic predictions. The field of peptidomics, focusing on peptide detection, has been around 
for almost 15 years and is predominantly based on mass spectrometry coupled to 
chromatographic techniques (LC and CE [28]) and on bioinformatics. We can refer to several 
reviews on this topic [27,29,30] and will only discuss the major improvements of the last 
years that specifically pertain peptidomics. Peptidomics hardware is identical to efficient shot-
gun proteomics hardware and has lately benefitted considerably from the introduction of 
improved mass spectrometers like Orbitraps [31], UPLC (ultra performance liquid 
chromatography) and the implementation of additional peptide fragmentation methods next to 
CID (collision induced dissociation), such as ETD (electron transfer dissociation) [32,33]. 
There are several important differences between peptidomics and proteomics, ranging from 
sample preparation to analysis strategies. Peptidomics analyses endogenous peptides, contrary 
to the tryptic peptides from bottom-up proteomics. Both proteomics and peptidomics aim to 
identify peptides from MS and especially MS/MS. These peptides are the analytical endpoints 
in the case of peptidomics or are used for protein inference in the case of proteomics. Mass 
spectrometry based peptide identification is most straightforward if the genome of the 
organism under investigation is known. The decreasing time and costs of genome sequencing 
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led to an increasing number of invertebrates having their transcriptome and/or genome 
sequenced and annotated which benefits future proteomic and peptidomic studies. Another 
cornerstone of efficient MS/MS data analysis is the expansion of MS/MS spectral databases. 
Proteomic MS/MS databases such as PRIDE [34] allow spectral matching of experimental 
MS/MS spectra with database-derived spectra (see further). There are nowadays neuropeptide 
information databases that also contain neuropeptide fragmentation spectra, such as SwePep 
[35]. More general neuropeptide databases are EROP-Moscow [36], PeptideDB [37] and 
Peptidome [38]. These all contain useful information, including numerous invertebrate 
sequences, aiding peptidomics and functional characterization experiments. 
 
 
2.1 Sample preparation 
 
The pioneering peptidomics experiments on invertebrates and vertebrates showed that there 
was a qualitative difference between samples from both groups reflected in the ratio of 
bioactive peptides to proteolytic peptides [39,40]. Vertebrate tissues are more prone to 
proteolytic degradation and require more stringent experimental conditions (low temperature, 
boiling, denaturing agents) in order to avoid contamination of the peptide extract by peptides 
originating from protein degradation. Invertebrate central nervous system (CNS) tissue, even 
separate cells, can be cleanly dissected and subsequent extraction procedures can enrich the 
sample with neuropeptides (see table 1 for the different peptidomics experiments on 
invertebrates) [40]. Whole-animal extracts (like for C. elegans [41]) usually require additional 
cleaning steps (like delipidation [42]). The highest quality of peptidomic extracts is achieved 
when neuroendocrine cell lines are available, whereby the cells themselves – or the secreted 
peptides after stimulation – can be extracted [43,44]. In many invertebrates, extraction can 
often be skipped and tissues may be analyzed through direct peptide profiling, in which whole 
tissues or organs are covered with a layer of matrix and directly analyzed through matrix-
assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS [45–47]. A recent 
development in sample preparation is the peptidomic profiling of paraformaldehyde-fixed 
immunolabeled neurons of the American cockroach Periplaneta americana [48], which 
enables the targeted peptidomic analysis of predefined cells. 
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2.2 MS data analysis 
 
The most straightforward identification of neuropeptides from MS data consists of comparing 
experimental peptide masses (MS1) with theoretical masses from a database (Fig. 2). 
Neuropeptide precursors can be found in genomics data by homology searches or multiple 
alignment tools [49], but there also exist bioinformatic methods to predict new possible 
precursors based on signal sequence and cleavage site occurrence and the presence of internal 
repeats, a precursor hallmark that is typical for invertebrates [50]. Afterwards, the peptide 
precursors are cleaved in silico by a cleavage site prediction tool such as NeuroPred [51] and 
the mass of the fragments is calculated. This approach requires prior knowledge of possible 
post-translational modifications. Bioactive peptide databases [36–38] also usually give the 
mono-isotopic mass and already contain information on possible modifications. These 
databases are of course only for species whose genome was already sequenced and annotated. 
Mass matching should be backed up by (previous) MS/MS experiments to confirm the 
identities of the putative neuropeptides.  
MS/MS data analysis of peptidomic experiments (Fig. 2) is inherently more difficult than for 
bottom-up proteomics where a protein is cleaved by trypsin. This is due to the general lack of 
C-terminal basic residues (which results in less predictable fragmentation patterns), more 
post-translational modifications and the fact that standard sequence database search engines 
require a proteolytic protein to be chosen to restrict the search space. Nonetheless, sequence 
database search robots like Mascot [52], Sequest [53] and X!Tandem [54] are a quick first 
step and will identify a decent amount of peptides if the genomic data is available for that 
species. Database searching algorithms are more accurate if re-scoring algorithms are used 
[55]. Peptidomics generally results in less peptide identifications than proteomics, and is 
therefore more amenable to manual or software-aided validation, which is strongly advised 
[56]. Searching against precursor databases (instead of the whole genome) increases the 
number of identifications (scoring functions usually give more significant scores if the 
database is smaller) and is justified if the selective extraction results in very low or negligible 
concentrations of proteolytic “background” peptides. Peptidomic database searches can also 
provide a basis for extra peptide identifications by clustering the high-quality unidentified 
spectra with the previously identified spectra. This allows to map modifications and isoforms 
on peptides identified by the database search [57].  
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Fig. 2: Mass spectrometry based methods for endogenous peptide identification. Both database-
dependent and de novo methods are schematically represented. Database-dependent methods include 
(A) mass matching based on single MS spectra, MS/MS-based database searches and (B) spectral 
matching. Mass matching requires databases with known neuropeptides or accurate prediction of 
genes and cleavage sites to calculate peptide masses from genomic databases. Database search engines 
score the similarities between theoretical and experimental MS/MS spectra. MS/MS databases allow 
searching for highly similar spectra. Clustering of MS/MS spectra can be used to find new 
modifications within an MS/MS dataset or to cluster MS/MS spectra of related species by similarity. 
De novo methods can be used independently or in combination with partial sequence tags to map 
peptides to the proteome or the genome. 
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Table 1. Summary of recent invertebrate peptidomic experiments for the identification of novel 
neuropeptides. Organism and organ/tissue from which the neuropeptides were extracted are listed. 
Invertebrate neuropeptides identified by MS (not necessarily in genome wide screenings) prior to 2006 
are listed in Hummon et al. [58]. CNS, central nervous system; CC, corpora cardiaca; CA, corpora 
allata; TG, thoracic ganglion. 
 
Organism/Classification Organ Reference 
Echinodermata 
Strongylocentrotus purpuratus radial nerve tissue [59] 
 
Nematoda 
Ascaris suum heads [60] 
Caenorhadbitis elegans whole organism [41] 
 
Chordata  
          Ascidiacea  
Ciona intestinalis neural tissue [61] 
 
Arthropoda 
          Insecta 
                    Blattodea 
Blatta orientalis CC, CA, neurons [62] 
Deropeltis spec. CC, CA, neurons [62] 
Eurycotis floridana CC, CA, neurons [62] 
Neostylopyga rhombifolia CC, CA, neurons [62] 
Periplaneta americana CC, CA, neurons [62] 
Periplaneta australasiae CC, CA, neurons [62] 
Periplaneta brunnea CC, CA, neurons [62] 
Periplaneta fuliginosa CC, CA, neurons [62] 
Shelfordella lateralis CC, CA, neurons [62] 
 
                    Coleoptera 
Tribolium castaneum CNS tissue [40,63] 
 
                    Diptera 
Aedes aegypti CNS tissue, CC, midgut, antennal lobe [64,65] 
Delia radicum CNS [66] 
Drosophila melanogaster CNS, neurohemal organs [40,67] 
Glossina morsitans CNS, CC, CA [68] 
Sarcophaga bullata CNS [69] 
 
                    Hemiptera 
Acrosternum hilare CC, neurohemal organs [46] 
Acyrthosiphon pisum brain [70] 
Banasa dimiata CC, neurohemal organs [46] 
Euschistus servus CC, neurohemal organs [46] 
Nezara viridula CC, neurohemal organs [46] 
Rhodnius prolixus  CNS tissue [71] 
 
                    Hymenoptera 
Apis mellifera CNS [72,73] 
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Nasonia vitripennis CNS ganglia, CA  [74] 
 
                    Lepidoptera 
Bombyx mori brain, CC, CA  [75] 
Galleria mellonella neuroendocrine tissue [71] 
 
                    Mantophasmatodea 
Mantophasma kudubergense CC, neurohemal organs [44] 
Namaquaphasma ookiepense CC, neurohemal organs [44] 
Striatophasma nauklutftense CC, neurohemal organs [44] 
 
                    Orthoptera 
Locusta migratoria CC, pars intercerebralis [24,56,73,74] 
Schistocerca gregaria CA [73,74] 
 
          Malacostraca 
                    Decapoda 
Callinectes sapidus Pericardial organs, sinus gland [79–83] 
Cancer borealis brain, thoracic ganglion [83,84] 
Cancer productus TG [85] 
Carcinus maenas  Pericardial organs [80] 
Hyas lyratus TG [85] 
Hemigrapsus nudus TG [85] 
Oregonia gracilis TG [85] 
Panulirus interruptus Sinus gland [83] 
Telmessus cheiragonus TG [85] 
 
          Branchiopoda 
Daphnia pulex brain-optic ganglia [86] 
 
Mollusca 
          Gastropoda 
Aplysia californica neurons [87] 
Lymnaea stagnalis Neurons, penial complex [88,89] 
 
On the other end of the MS/MS analysis spectrum are de novo sequencing tools (Fig. 2), like 
PepNovo [90] and Peaks [91], which do not use prior information to identify peptides. This 
has the advantage of not relying on genomic information, correct protein translation and 
presumed modifications or cleavage sites. However, only high-quality spectra can be fully 
sequenced de novo. Sequencing multiple short stretches (PSTs or partial sequence tags) of an 
MS/MS spectrum is usually feasible by programs like DirecTag [92]. If multiple (n > 1) PSTs 
are available for a single MS/MS spectrum (or a completely sequenced spectrum), methods 
exist that will map these PSTs to all six reading frames of a genome [59,93,94]. This is 
interesting since it circumvents problems related to annotation (if the organism has no close 
evolutionary relatives with explored neuropeptidomes) and has for example been successfully 
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applied to the sea urchin [59]. De novo sequencing tags are also used to limit the size of a 
database in a database search [95]. 
MS/MS data from peptidomics experiments should ideally be publically available for spectral 
matching by algorithms such as SpectraST [96], X!Hunter [97] and BiblioSpec [98]. The lack 
of a centralized public database reflects the less matured stage of peptidomics compared to 
proteomics. However, there are various groups that have their own stored neuropeptide 
MS/MS data. Clustering of peptidomic MS/MS data from species (of which one is well 
characterized) allows the identification of neuropeptides, even if the genome is not or 
incompletely sequenced [78]. Taken together, the ongoing sequencing efforts, the expanding 
neuropeptide spectral databases and the peptidomics specific bioinformatics approaches [99] 
have developed the field of peptidomics to a point where an organism’s neuropeptidome can 
be charted in depth within reasonable time. 
 
3. Differential peptidomics 
Differential peptidomics focuses on the comparison of peptide profiles between biological 
samples and correlates peptide expression levels to a phenotype of interest, ultimately 
formulating working hypotheses on the involvement of the neuropeptide (Fig. 3A). The 
peptidome-wide screening of neuropeptides is a good starting point for further functional 
characterization and differential peptidomics is as such complementary to the reverse 
approaches discussed later on. Differential peptidomics can be separated into two 
subdomains: focusing on qualitative or quantitative comparisons. Historically, differential 
peptidomics mainly focused on qualitative comparisons between samples, identifying peptide 
peaks that are (near)-absent in one sample but abundant in another. More recently, 
quantitative peptidomics studies are gaining traction and are being used for the – usually 
relative – quantification of peptide profiles. Various approaches exist for both qualitative and 
quantitative differential peptidomics and all have potential uses within the field of 
invertebrate peptidomics. 
 
3.1 Qualitative comparisons 
Qualitative differential peptidomics essentially does not differ much from standard 
peptidomics techniques used to detect and identify peptide profiles. In qualitative differential 
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peptidomics, peptide profiles are attained using standardized procedures, usually through off-
line reverse phase high-performance liquid chromatography (RP-HPLC) and subsequent 
MALDI-TOF MS [100,101]. For single invertebrate tissues, the extraction and HPLC step is 
often even skipped and extracts are analyzed and compared through direct profiling (see 
section 2.1) [45,46]. By using the same standardized procedures to extract and detect peptides 
from samples, it is possible to manually compare peptide profiles to detect peaks absent in 
one sample but abundant in another. 
Qualitative comparisons have shown their use in several invertebrate research domains where 
large differences in peptide profiles are expected. For example, qualitative differential 
peptidomics techniques were used to identify immune-inducible peptides in the hemolymph 
of D. melanogaster [102–104]. Again in D. melanogaster, qualitative comparisons were used 
to show that that the peptidome of its neurohemal organs does not radically change during 
metamorphosis [105]. Peptide profiles were similarly compared to identify peptides 
potentially contributing to phase transition in locusts [106,107] and to diapausing Colorado 
potato beetles (Leptinotarsa decemlineata) [100]. In C. elegans, qualitative comparisons were 
used to profile a set of peptide processing enzymes, including proprotein convertases required 
for cleaving peptides from their proprotein precursors [5,108]. 
Qualitative comparisons are also commonly used to profile evolutionary conservation of 
neuropeptides between closely related species and were used, for example, for comparisons 
between C. elegans and Caenorhabditis briggsae [101] and different insect species 
[45,46,109]. 
 
3.2 Quantitative peptidomics 
Quantitative peptidomics is largely based on quantitative proteomics, with one main 
exception: popular gel-based proteomics methods cannot be used for quantitative peptidomics 
as peptides do not separate well on gels due to their small size. Many of the remaining 
differential gel-free proteomics methods have been successfully adapted for use in 
quantitative peptidomics, including both label-based and label-free methods. However, while 
many qualitative proteomics approaches have been largely automated [110,111], quantitative 
peptidomics often requires laborious manual analysis of data [72,80,112]. 
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Fig. 3: Schematic overview of potential approaches for functional peptidomics. A In a forward 
approach, a phenotype of interest (e.g. a disease or a clear phenotype resulting from a singular 
mutation) is chosen for study, with the intention of discovering which peptides influence it. 
Differential peptidomics techniques, comparing control and experimental samples, are used in order to 
construct a list of peptides that potentially contribute to the phenotype of interest. B Using the reverse 
approach, an identified peptide (or receptor) with unknown function is used as the object of study. By 
functionally characterizing the peptide (e.g. through receptor screens or localization studies), the 
phenotypes it influences may eventually be revealed. 
Label-based techniques have the benefit that differentially labeled samples can be pooled 
prior to LC-MS analysis, reducing between-run variability. Label-based differential 
peptidomics depend on either metabolic or chemical differential labeling in order to discern 
samples during mass spectrometry. The metabolic labeling technique that is most compatible 
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with multicellular organisms is the stable isotope labeling with amino acids in cell cultures 
(SILAC) [113] technique. In SILAC, cell cultures (or animals) are provided with stable 
isotopic variants of amino acids, after which they are integrated during growth. While 
complete incorporation of these isotopic variants is difficult in larger species [114], SILAC 
has already been adapted for use in both D. melanogaster [115] and C. elegans [114] 
proteomics, implying that SILAC may be used for peptidomics in these species as well. 
Chemical labeling differs from metabolic labeling in that samples are labeled after extraction, 
instead of during growth, potentially adding more experimental variation to the peptidomics 
experiment. Popular isotopic chemical labels used for peptidomics include 4-
trimethylammoniumbutyryl (TMAB) [112] and succinic anhydride [112,116]. These labels 
are often chosen due to their ability to bind amines, in contrast to cysteine-binding labels, 
such as isotope-coded affinity tags [117], as not all endogenous peptides contain cysteine 
residues. Amine-binding isobaric tags such as tandem mass tags (TMT) [118], isobaric tags 
for relative and absolute quantification (iTRAQ) [119], and N,N-dimethyl leucines (DiLeu) 
[79], which are generally used for differential proteomics, have also been adapted for use in 
differential peptidomics. Isobaric tags differ from isotopic tags in that the total mass of each 
label does not differ from each other, but each different label releases a reporter ion with 
different mass upon fragmentation during mass spectrometric analysis, thus still allowing 
differentiation of each sample [118]. In addition to these label-based techniques, label-free 
proteomics techniques have also been successfully adapted for use in peptidomics [120]. 
Label-free techniques require separate LC-MS runs for each sample, thus making between 
run-variability a potential confounding factor in quantitative analysis [121]. However, label-
free techniques also have advantages over chemical labeling techniques, including the ability 
to quantify peptides with modified amine residues. For a more comprehensive review 
regarding techniques used for quantitative peptidomics, including advantages and 
disadvantages of each technique, see Romanova et al. [122]. 
Invertebrate organisms are ideally suited for high-throughput quantitative peptidomics due to 
the relatively low complexity of their peptidome and the ease by which single tissues can be 
collected, extracted and compared, further lowering sample complexity. Nevertheless, only 
few quantitative peptidomics studies have been performed in invertebrates. In the large sea 
slug Aplysia californica, a model often used for the study of neurobiology, learning and 
behavior, both succinic anhydride and isobaric iTRAQ tags were successfully employed to 
compare neuropeptide profiles between individual neurons and tissue, revealing the relative 
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ease by which peptides can be quantified in invertebrate models [116]. In the honey bee A. 
mellifera, isotopic labeling with succinic anhydride was used to compare brain neuropeptide 
profiles between nurses and foragers and between nectar and pollen foragers, through which 8 
highly dynamic peptides that may be involved in the regulation of honey bee behavior were 
identified [72]. Isobaric DiLeu labeling was employed to determine changes in endogenous 
peptide concentrations in the gut and salivary glands of the assassin bug Rhodnius prolixus in 
relation to feeding, revealing potential peptides involved in the postprandial endocrine 
response in this disease vector [71]. In the same vein, isobaric and isotopic labeling were used 
to investigate the neuropeptidergic responses of crustacean species to salinity stress [80] and 
feeding [123] respectively. 
Invertebrate quantitative peptidomics has a promising future ahead. The studies listed above 
illustrate how tissues [71,72] or even single neurons [116] can be compared, which can be 
invaluable for the study of (neuro-)endocrinological modulation of processes such as behavior 
in invertebrate model systems. It is important to note that such forward studies (Fig. 3) only 
provide a list of interesting targets, and that their involvement in the studied phenotype needs 
to be validated. Several invertebrate models generally allow straightforward validation of data 
due to the existence of extensive genetic toolsets (see section 4.3). 
Importantly, many biological processes in invertebrates are regulated by the endocrine 
system, although thorough understanding of this endocrine regulation is often lacking. The 
nematode C. elegans is often used as a model organism for the study of aging, and endocrine 
signaling has a key role in the regulation of longevity in this worm (as reviewed by Kleemann 
and Murphy [124] and Panowski and Dillin [125]). However, the identities of the signaling 
molecules involved in this endocrine regulation of aging are largely unknown. As C. elegans 
has a rich diversity in both endogenous neuropeptides and peptide GPCRs (as reviewed by 
Frooninckx et al. [8]), it seems likely that neuropeptidergic signaling is at least partly 
responsible for this endocrine regulation of longevity. Quantitative peptidomics may provide 
the tools necessary to finally solve these remaining mysteries. 
 
4. Functional characterization of neuropeptides 
The majority of neuropeptides exert their function by binding to plasma membrane-associated 
receptors known as G-protein coupled receptors (GPCRs), resulting in the activation of 
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intracellular signaling pathways (for encompassing reviews about neuropeptide GPCRs, see 
the reviews by Frooninckx et al. [8] about C. elegans GPCRs and by Caers et al. [9] about 
insect GPCRs). While the previously discussed differential peptidomics techniques can be 
used to investigate the involvement of neuropeptides (Fig. 3A) in the regulation of a 
phenotype of interest, neuropeptides are often studied in reverse (Fig. 3B). By studying and 
functionally characterizing an identified peptide (or receptor), the phenotypes it influences 
may eventually be revealed. Here we will discuss different strategies for identifying 
neuropeptide-receptor pairs, peptide and receptor localization and functional tests. Studies in 
the popular model organisms D. melanogaster and C. elegans that are based on peptidome-
wide screening and characterization are presented in table 2. 
 
4.1 Deorphanization and receptor identification 
 
In the past, novel GPCRs were often identified by screening cDNA libraries with low-
stringency oligonucleotide probes [126] and degenerate polymerase chain reaction (PCR) 
experimental techniques [127]. One of the drawbacks of this approach, in which GPCRs are 
identified exclusively via homology, is that the endogenous ligands are almost always 
unknown, resulting in so called ‘orphan receptors’ [128]. 
An essential step in the characterization of a predicted neuropeptide GPCR is the 
identification of its natural ligand(s), called  ‘deorphanization’. Knowledge of functionally 
active neuropeptide-receptor couples and GPCR affinity is crucial to understand how 
neuropeptides function and modulate neural circuits. When a new neuropeptide is found (e.g. 
by detection in a sample or a de novo prediction), one of the main questions that arises is 
which receptor(s) it activates to exert its function. The same goes for novel neuropeptide 
receptors: what is the range of ligands that bind this receptor and at what affinity? In the post-
genomic era these questions are commonly answered using a ‘reverse pharmacology’ 
approach (Fig. 4), in which GPCRs are heterologous expressed in cultured cells and used as 
targets for screening the neuropeptidome.  
 
4.1.1 Mammalian cells as heterologous expression systems for GPCR screens 
 
Throughout the years, immortalized mammalian cell lines have become very popular 
expression systems for the deorphanization of GPCRs. The most widely used host mammalian  
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Table 2. C. elegans and D. melanogaster neuropeptide receptors characterized by a peptidome-wide approach. Table partially adapted from [8,9,129]. 
Organism Receptor name 
Receptor accession 
number 
Activating peptides References 
C. elegans CKR-2E Y39A3B.5c/b NLP12a; NLP-12b [130] 
 
CKR-2F Y39A3B.5c/d NLP12a; NLP-12b [130] 
 
EGL-6A C46F4.1a FPL-10; FLP-17a, FLP-17b [131] 
 
EGL-6B C46F4.1b FPL-10; FLP-17a, FLP-17b [131] 
 
FRPR-18A T19F4.1a FLP-2a; FLP-2b [132] 
 
FRPR-18B T19F4.1b FLP-2a; FLP-2b [132] 
 FRPR-3 C26F1.6 FLP-7a; FLP-11a [133] 
 
GNRR-1A F54D7.3a NLP-47 [21] 
 
NMUR-2 K10B4.4 NLP-44 [134] 
 NPR-1 C39E6.6 FLP-18b; FLP-18c; FLP-18d; FLP-18e; FLP-18f; FLP-18g ; FLP-21 [135] 
 NPR-10A C53C7.1a 
FLP-3a; FLP-3c; FLP-3e; FLP-3f; FLP-3g; FLP-3h; FLP-18c; FLP-
18d; FLP-18e; FLP-18f; FLP-18g 
[136] 
 NPR-10B C53C7.1b 
FLP-3a; FLP-3c; FLP-3e; FLP-3f; FLP-3g; FLP-3h; FLP-18c; FLP-
18d; FLP-18e; FLP-18f; FLP-18g 
[136] 
 NPR-11 C25G6.5 NLP-1a; FPL-1f; FLP-5b; FLP-14; FLP-18c; FLP-21 [136] 
 NPR-22A Y59H11AL.1a FLP-7c [137] 
 NPR-3 C10C6.2 FLP-15a; FLP-15b; FLP-15c [138] 
 NPR-4 C16D6.2 
FLP-1f; FLP-4b; FLP-18b; FLP-18c; FLP-18d; FLP-18e; FLP-18f; 
FLP-18g 
[136] 
 NPR-5A Y58G8A.4a 
FLP-1b; FLP-3a; FLP-3f; FLP-3g; FLP-3h; FLP-18b; FLP-18c; 
FLP18-d; FLP-18e; FLP-18f; FLP-18g; FLP-21 
[136,139,140] 
 NPR-5B Y58G8A.4b 
FLP-1b; FLP-3a; FLP-3f; FLP-3g; FLP-3h; FLP-18b; FLP-18c; 
FLP18-d; FLP-18e; FLP-18f; FLP-18g; FLP-21 
[136,139,140] 
 NPR-6 F41E7.3 FLP-15a [136] 
 
NTR-1 T07D10.2 NTC-1 [13] 
 
PDFR-1A C13B9.4a PDF-1a; PDF-1b; PDF-2 [141] 
 
PDFR-1B C13B9.4b  PDF-1a; PDF-1b; PDF-2 [141] 
 
PDFR-1C C13B9.4c PDF-1a; PDF-1b; PDF-2 [141] 
D. melanogaster AKHR CG11325 AKH [142] 
 ASTA-R1 CG2872 ASTA1-4 [143,144] 
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 ASTA-R2 CG10001 ASTA1-4 [144,145] 
 ASTC-R1 CG7285 ASTC [146] 
 ASTC-R2 CG13702 ASTC [146] 
 CAPAR CG14575 CAPA-PVK1-2 [147] 
 CCHa1-R CG30106 CCHa1-2 [148] 
 CCHa2-R CG14593 CCHa1-2 [148] 
 CRZR CG10698 CRZ [149] 
 FMRFaR CG2114 dFMRFa1-8 [150] 
 MSR1 CG8985 DMS [151] 
 MSR2 CG13803 DMS [151] 
 PK1-R CG9918 CAPA-PK1 [152] 
 PK2-R1 CG8784 Hugin-PK2 [153] 
 PK2-R2 CG8795 CAPA-PK2 [153] 
 Proc-R CG6986 Proctolin [154] 
 SPR CG16752 SP; MIP1-5 [155,156] 
 DH31-R CG32843 DH31 [157] 
 CCKLR-17D1 CG42301 DSK1-2 [158] 
 DH44-R1 CG8422 DH44 [159] 
 DH44-R2 CG12370 DH44 [160] 
 CCAP-R CG33344 CCAP [161] 
 ETHR CG5911 ETH1-2 [162] 
 LGR1 CG7665 GPA2/GPB5 [163] 
 LKR CG10626 Leucokinin [164] 
 NPFR CG1147 NPF [165] 
 PDFR CG13758 PDF [166,167] 
 RK CG8930 Burs [168] 
 RYa-R CG5811 RYa [169] 
 sNPF-R CG7395 sNPF1-4 [170] 
 SIFaR CG10823 SIFa [171] 
 CCKLR-17D3 CG32540 DSK1-2 [172] 
 TKR86C CG6515 DTK-1-6 [173] 
 TKR99D CG7887 DTK-6 [174] 
 TrissinR CG34381 Trissin [175] 
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cell lines are Chinese Hamster Ovary (CHO) cells and Human Embryonic Kidney (HEK) 293 
cells due to their high efficiency of transfection and faithful translation and processing of 
proteins [176,177]. Alternative expression systems include yeast and insect cells as well as 
Xenopus laevis oocytes and melanophores [164,178–182].  
In addition to selecting an appropriate heterologous expression system, an accurate and 
broadly applicable platform to measure GPCR activation is required. By monitoring 
downstream events of the GPCR signaling transduction cascade, such as second messenger 
activity and transcription of target genes, many different strategies have been developed for 
the detection of GPCR activation in mammalian cells [183,184]. Many of the cell-based 
assays rely on the expression of promiscuous G-protein α subunits or chimeric G-proteins, 
which renders them applicable to all GPCRs regardless of the endogenous G-protein coupling 
and consequently eliminates the need for prior knowledge of the interacting G-protein 
[185,186]. 
 
4.1.1.1 Intracellular calcium mobilization 
Calcium mobilization assays lend themselves perfectly to high-throughput orphan receptor 
screening and are therefore routinely used in both pharmaceutical companies and academic 
institutes. They detect GPCR activation through changes in intracellular calcium (Ca
2+
) 
concentration, which acts as a secondary messenger. The resulting increase in intracellular 
Ca
2+
 concentration can be monitored using fluorescent dyes, such as Fluo-3 and Fluo-4, or 
Ca
2+
-sensitive biosensors, such as aequorin, a bioluminescent protein isolated from the 
hydrozoan jellyfish Aequorea victoria [187]. 
 
4.1.1.2 Intracellular cAMP concentration 
Measuring the change in intracellular cyclic adenosine 3’,5’-monophosphate (cAMP) levels is 
another (deorphanization) strategy, which, similar to the principle of calcium mobilization 
assays, relies on a second messenger molecule as a functional readout of Gαs-coupled GPCR 
activation. A variety of cAMP detection methods have been developed to quantify the 
activation of such GPCRs. They can essentially be divided into two broad categories: (1) 
accumulation assays, which are based on the competition between cellular cAMP and 
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exogenously added labeled cAMP for binding to a limited number of anti-cAMP antibody 
binding sites, and (2) reporter gene assays, in which receptor activation is measured via 
changes in the expression level of a selected reporter gene (as reviewed by Gabriel et al. [188] 
and Williams [189]).  
 
4.1.1.3 β-arrestin tagging 
Another popular deorphanization method, β-arrestin tagging, relies on a universally shared 
GPCR feature instead of specific G protein signaling pathways that differ from receptor to 
receptor. In particular, it depends on the way by which signaling is terminated. Almost all 
GPCRs are deactivated by GPCR-regulatory-kinases (GRKs) which phosphorylate the C-
terminal side of the receptor. This results in recruitment of β-arrestins from the cytosol to the 
phosphorylated sites and subsequent receptor desensitization and internalization [128]. By 
tagging β-arrestin molecules with a fluorescent protein such as GFP, it is possible to visualize 
their translocation from the cytosol to the cell membrane (and vice versa). Thus, by means of 
a protein redistribution assay it is possible to visualize GPCR (de)activation in living cells 
[190]. Using this technique, several GPCRs in Drosophila have been deorphaned after 
transiently expressing them in HEK cells [191]. 
As β-arrestin tagging historically required automated confocal systems and subsequent image 
analysis [184], this technique for GPCR deorphanization is less commonly used compared to 
more straightforward techniques measuring calcium mobilization or cAMP concentration. 
However, β-arrestin tagging provides some advantages, including that activity is measured 
upstream at the GPCR level – compared to downstream cAMP or calcium levels – and is thus 
completely independent of G protein activity [192]. Novel techniques utilizing β-arrestin tags 
no longer require laborious image analysis and are instead based on the detection of 
fluorescent or chemiluminescent reporter signals [193,194]. 
 
4.1.2 A perspective on GPCR deorphanization in invertebrates 
 
A significant amount of initial work in the field of GPCR deorphanization was performed on 
D. melanogaster. In 1991, Li and colleagues were the first to clone and functionally 
characterized an insect GPCR [195], namely the Drosophila tachykinin-like receptor. After 
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Fig. 4: Graphical overview of the different approaches leading to receptor deorphanization. 
Typically, a neuropeptide library (based on peptidomics data and/or in silico predictions) is used to 
screen for receptor-binding. The receptor of interest is expressed in cultured cells and one or more 
assays, often based on measuring increased concentrations of secondary messengers (such as cAMP or 
Ca
2+
), augmented fluorescence or altered impedance, are used to obtain a functional read-out of 
receptor activation for each potential ligand. Using this process, it is possible to identify the natural 
ligand(s) of putative neuropeptide receptors. 
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publication of the D. melanogaster genome [196], the development of (neuro)-peptidomics 
accelerated. Based on genomic data, it became possible to predict a large number of 
neuropeptide receptors and neuropeptide precursors [197,198]. During the following years, 
over a dozen GPCR neuropeptide receptors were identified and their signaling systems 
characterized. A comprehensive overview of early D. melanogaster (neuro)peptide research 
can be found in the literature [9,129,199].  
While great progress was made in characterizing neuropeptides, even in the extensively 
studied model organisms D. melanogaster and C. elegans, the majority of neuropeptide 
receptors remain orphan, awaiting for their endogenous ligand(s) to be determined [8,9]. So 
far only 18% of the predicted C. elegans GPCRs (isoforms included) could be deorphaned 
[200]. A recent large-scale initiative, titled “the Peptide-GPCR project”, aims to bridge this 
gap by matching all predicted peptide C. elegans GPCRs tot their cognate neuropeptide 
ligand(s). The project’s goal is to characterize novel neuropeptide-GPCR couples and GPCR 
affinity using a combined reverse pharmacology approach. Peptide GPCRs will be randomly 
screened with a library of over 260 peptides belonging to the FMRFamide-related peptide and 
neuropeptide-like protein families (Isabel Beets, Personal Communication). An in vitro 
calcium mobilization strategy allows screening of these peptides on all putative peptide 
GPCRs in a high-throughput manner. Community members are invited to steer the project’s 
progression (via https://worm.peptide-gpcr.org/). 
 
4.1.3 Neuropeptides as receptor tyrosine kinase activators 
 
While GCPRs are by far the most common receptors for neuropeptides, some neuropeptides 
activate receptor tyrosine kinases (RTKs) instead. While high-throughput receptor screens are 
not as commonly used for receptor tyrosine kinases due to the lack of a unified cellular 
response to their activation, a cellular assay to study their activation using a microelectronic 
sensor array has been developed [201]. Additionally, receptor tyrosine kinases 
autophosphorylate when activated, which allows their activation to be studied using targeted 
antibodies in a western blot [202]. 
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4.2 Localization of neuropeptides 
 
Determining the expression patterns of neuropeptide genes can provide us with a great 
amount of information and clues as to their biological function. Likewise, knowledge about 
the cellular localization of the accompanying neuropeptide receptor can be important to 
deduce the possible role of the neuropeptide signaling system. There are several possible tools 
to study the distribution pattern of neuropeptides and their cognate receptors. The most 
popular are immunocytochemistry, in situ hybridization and the use of reporter genes. More 
recently, imaging mass spectrometry (IMS) [203] has emerged as a promising technique for 
identifying peptides and proteins and their spatial localization in tissues simultaneously based 
on their molecular masses.  
 
4.2.1 Immunocytochemistry 
Our knowledge about the distribution of neuropeptides and their receptors in the nervous 
system of invertebrates has been greatly advanced by the use of immunocytochemistry [204–
209]. This technique relies on specific antibodies to assess the presence of a protein or antigen 
in tissues and cells. The major drawback to using this approach for the localization of 
neuropeptides is cross-reactivity [210]. Many peptide antibodies do also recognize related or 
unrelated molecules due to sequence similarity with the proteins used to raise the antisera. As 
neuropeptides often exist in different isoforms and sequence similarities among members of 
the same neuropeptide family are readily apparent, it can be challenging to specifically detect 
the localization of a particular peptide by immunocytochemistry.  
4.2.2 In situ hybridization 
Knowing the DNA sequence of neuropeptides and their cognate receptors provides the 
opportunity to localize and detect the physical position of their corresponding messenger 
RNA sequences (mRNAs) by in situ hybridization. The core principle of this approach rests 
on hybridization between a labeled single-stranded nucleic acid probe and a complementary 
sequence within the target mRNA. The resulting duplexes can be visualized by standard label 
detection techniques. Traditional histochemical RNA detection methods use radiolabeled 
complementary DNA or RNA strands for identifying specific mRNA species in tissue 
sections. Nowadays, non-radioactive hybridization probes have become a superior alternative 
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over radioactive approaches [211]. As with immunocytochemistry, direct as well as indirect 
labeling methods are available. Wisely designed oligonucleotide probes allow for 
discrimination between closely related gene family members and different splice variants. 
4.2.3 Reporter genes 
Gene expression patterns can be visualized either directly by using nucleic acid probes (in situ 
hybridization) and antibodies (immunocytochemistry), or indirectly by using easily detectable 
reporter genes. To examine the spatial expression of neuropeptide genes, the promoter region 
of the neuropeptide precursor and the coding region of the reporter gene are fused together 
and the resulting transcriptional reporter constructs are then inserted into the organism. In 
addition, translational reporters can be used which include additional regulatory information 
that may be present in introns or 3′UTRs. These constructs comprise the entire genomic locus 
of the neuropeptide precursor gene (including 5’UTR, introns, exons and 3’UTRs) fused to 
the reporter gene coding sequence.  
Genes encoding fluorescent proteins are frequently used as reporters of gene expression [212]. 
Naturally occurring fluorescent proteins, such as the green fluorescent protein (GFP) isolated 
from the jellyfish Aequorea victoria, and the red fluorescent protein (dsRed) derived from the 
sea anemone Discosoma sp., have, however, several undesirable physical properties such as 
reduced protein stability, decreased brightness and insufficient photostability, which limits 
their usefulness as an imaging tool [213]. Many of the adverse properties have been overcome 
by site-directed and random mutagenesis and this protein engineering created a plethora of 
reliable fluorescent protein variants in various spectral regions (blue, cyan, green, yellow, 
orange, red and far-red) [214]. 
C. elegans is especially well suited for the use of fluorescent protein markers for gene 
expression studies and protein localization [215]. The worm’s small size and transparency 
facilitates non-invasive microscopy and allows for in vivo localization of neuropeptide 
signaling components. In addition, transgenic animals can be readily generated via 
microinjection of foreign DNA fragments into the distal arm of the gonad [216]. There are 
several approaches for generating reporter constructs in C. elegans [215], including standard 
cloning techniques [217,218] or a PCR-fusion based approach [219].  
In Drosophila, the localization of neuropeptides can also be easily studied with reporter genes 
using the GAL4/UAS binary system [220,221]. GAL4, originally identified in the yeast 
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Saccharomyces cerevisiae, activates the transcription of genes containing Upstream 
Activating Sequences (UAS) by directly binding to these regulatory elements. For the study 
of neuropeptide expression patterns, the GAL4 gene is placed under the control of a 
neuropeptide precursor promoter, while expression of the reporter gene is driven by the 
presence of the UAS element. As a result, the reporter gene will only be transcribed in the 
cells where GAL4 is present, this is to say, in cells where the neuropeptide precursor gene is 
usually active. 
4.2.4 MS imaging 
MALDI IMS combines spatial analysis with mass spectrometry to analyze the distribution of 
small molecules, such as peptides, in a tissue. In short, thin tissue sections – or in the case of 
smaller invertebrates, whole tissues – are mounted on a MALDI target and embedded in 
matrix, after which specific sites on the tissue can be excited using the MALDI laser 
[203,222]. MALDI IMS allows one to directly examine the spatial presence of known and 
predicted peptides in different tissues. Direct MS profiling of neuronal tissues, instead of 
using other histological techniques, bypasses the need for lengthy extraction procedures and 
allows for the creation of a detailed neuropeptide expression map. 
IMS can be used for comparative or explorative analyses of different invertebrate tissues. The 
Li group pioneered the IMS characterization of crustaceans using various MS platforms on 
different species (as reviewed by Yu et al. [223]). For example, an IMS study on both 
pericardial organ and brain of the Jonah crab, Cancer borealis, elucidated the spatial 
relationship between multiple neuropeptide isoforms of the same family as well as the relative 
distributions of neuropeptide families [224]. In addition to planar 2D images, a detailed 3D 
map of the neuropeptide and lipid distribution in the C. borealis brain was created using 2D 
information of serial sections [225]. In the blue crab Callinectes sapidus, a combination of 
MALDI-TOF/TOF and MALDI-FT-ICR was performed to map the whole stomatogastric 
nervous system at the network level [226]. Other research groups have similarly adapted IMS 
for the mapping of peptide expression in other species. For example, MALDI IMS was 
successfully used to study neuropeptide localization in both the locust S. gregaria [227] and 
the cockroach Periplaneta americana [228]. In the honey bee A. mellifera, MALDI IMS was 
used to uncover the spatial and temporal distribution of specific neuropeptides in the worker 
brain, revealing a possible correlation between the localization of certain neuropeptides and 
age-related division of labor [229]. IMS analysis also revealed the localization of several 
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peptides in the nervous structure of the parasitic nematode Ascaris suum, further showing that 
peptide expression profiles are largely unique for each nervous structure in this parasitic 
worm [230]. In the shrimp Penaeus monodon, IMS analysis revealed differential distribution 
of several neuropeptides over various neuronal tissues, and also resulted in the addition 
identification of a novel tachykinin-related peptide [231].  
4.3 Functional characterization 
Receptor identification and localization of the neuropeptide and its receptor provide valuable 
information that may lead to the elucidation of a neuropeptide’s function. Knockdown (using 
RNA interference [RNAi]) or knockout of the neuropeptide (or receptor) gene and subsequent 
hypothesis-driven tests – based on the previously attained data – are the most often used 
approaches to fully functionally characterize a neuropeptide and its receptor. These 
approaches are especially powerful in the popular model organisms D. melanogaster and C. 
elegans, due to the existence of extensive genetic toolsets in both these invertebrates 
(including RNAi libraries and commercially available mutant or transgenic strains). In 
Drosophila for example, a reverse approach (Fig. 3) has led to the characterization of the 
Drosophila adipokinetic hormone and its effect on energy mobilization [232,233]. In C. 
elegans, examples of reverse approaches leading to the characterization of a peptide-receptor 
pair include the characterization of a gonadotropin-releasing hormone-like peptide as a 
regulator of reproduction [21] and a functional study linking a vasopressin/oxytocin-related 
peptide to associative learning [13]. In most invertebrates, it is also possible to directly inject 
a neuropeptide in order to study its effects on a chosen phenotype. For example, two 
approaches – knocking down the receptor through RNAi and direct injection of the peptide – 
were recently used to functionally characterize the short neuropeptide F and its effect on 
feeding in the locust S. gregaria [234].  
 
5. Future perspectives 
Peptidergic signaling is evolutionarily ancient, since even the earliest animal taxa like 
Cnidaria have neuropeptides. Many invertebrate neuropeptides have conserved homologs in 
vertebrate lineages [206]. Further exploration of both the invertebrate and vertebrate 
neuropeptidomes and receptors will enable us to investigate the molecular evolution of 
peptidergic signaling units throughout evolution. Now we have reached a point where the 
neuropeptidome can be comprehensively charted on the genomic and peptidomic level within 
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a time span of a few months. The ease of neuropeptidomic profiling increases with each 
sequenced genome and freely available neuropeptide spectral dataset. The neuropeptidome by 
itself contains functional information, mainly on the structural level. The exploration of more 
and more invertebrate genomes and neuropeptidomes will allow us to accurately determine 
the information-rich positions (constrained by evolution) in all neuropeptide classes, which 
will enhance the design and development of peptidomimetics. Hence, well-conserved peptides 
are prime candidates for receptor binding screens.  
Differential neuropeptidomics is a first step in the functional characterization of newly found 
peptides. The experimental setup of differential peptidomics is closely related to gel-free 
quantitative approaches and has also reached the level where it can handle the complexity of 
the neuropeptidome very well (a selective neuropeptide extraction results in a less complex 
sample than a tryptic digest of proteins). It is therefore an ideal phenotype-centered screening 
method that can be scaled up for screening the possible roles of neuropeptides in 
developmental and physiological processes and invertebrate models of human diseases [11]. 
Differential peptidomics is complementary to other more labor-intensive phenotypic 
screening techniques such as neuropeptide-related knock-outs and RNAi screens. Such 
reverse functional characterization is as yet not applicable on a large scale, though it 
progressed cumulatively the last decades. Current ongoing projects aim to find as many 
invertebrate peptide-receptor pairs as possible. It is therefore expected that the importance of 
invertebrate model systems will even further increase during the next decade. More complete 
knowledge of the neuronal and endocrine regulation of insect physiology can provide 
necessary answers for the control of pest species and disease vectors, and stimulate the 
progression of invertebrate models of human diseases. 
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